Sedation and analgesia in intensive care: A comparison of fentanyl and remifentanil

Pain Research and Treatment

Volumn 2011, Issue , 2011, Pages

  Cevik, F ^a   Celik, M ^b   Clark, P M ^c   MacIt, C ^c  

^a Abbott Pharmaceuticals   (Turkey)

^b ICU Department   (Turkey)

^c YEDITEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873819584     PISSN: 20901542     EISSN: 20901550     Source Type: Journal    
DOI: 10.1155/2011/650320     Document Type: Article

References (27)

1. Costa M. G., Chiarandini P., Rocca G. D., Sedation in the critically Ill patient. Transplantation Proceedings 2006 38 3 803 804 2-s2.0-33646090852 10.1016/j.transproceed.2006.01.038
2. Jacobi J., Fraser G. L., Coursin D. B., Riker R. R., Fontaine D., Wittbrodt E. T., Chalfin D. B., Masica M. F., Bjerke H. S., Coplin W. M., Crippen D. W., Fuchs B. D., Kelleher R. M., Marik P. E., Nasraway S. A., Murray M. J., Peruzzi W. T., Lumb P. D., Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Critical Care Medicine 2002 30 1 119 141 2-s2.0-0036152552 (Pubitemid 34112188)
3. Muellejans B., López A., Cross M. H., Bonome C., Morrison L., Kirkham A. J., Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial. Critical Care 2004 8 1 R1 R11 2-s2.0-2342635166
4. Park G., Coursin D., Ely E. W., England M., Fraser G. L., Mantz J., McKinley S., Ramsay M., Scholz J., Singer M., Sladen R., Vender J. S., Wild L., Balancing sedation and analgesia in the critically ill. Critical Care Clinics 2001 17 4 1015 1027 2-s2.0-0035189375 (Pubitemid 33103764)
5. What is Clinical Pharmacy? ESCP, http://www.escpweb.org/cms/Clinical- pharmacy
6. Schweickert W. D., Kress J. P., Strategies to optimize analgesia and sedation. Critical Care 2008 12 supplement 3 S6 2-s2.0-45949099795 10.1186/cc6151 (Pubitemid 351891486)
7. Kress J. P., Pohlman A. S., O'Connor M. F., Hall J. B., Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. New England Journal of Medicine 2000 342 20 1471 1477 2-s2.0-0034682246 10.1056/NEJM200005183422002 (Pubitemid 30318270)
8. Kuhlen R., Putensen C., Remifentanil for analgesia-based sedation in the intensive care unit. Critical Care 2004 8 1 13 14 2-s2.0-1042280972 10.1186/cc2421 (Pubitemid 38195566)
9. Cigada M., Corbella D., Mistraletti G., Forster C. R., Tommasino C., Morabito A., Iapichino G., Conscious sedation in the critically ill ventilated patient. Journal of Critical Care 2008 23 3 349 353 2-s2.0-49749115227 10.1016/j.jcrc.2007.04.003
10. Akinci S. B., Saricaoǧlu F., Kanbak M., Remifentanil ve fentanilin yoǧun bakim hastalarinda analjezi bazli sedasyon karşilaş tirilmasi Anestezi Dergisi 2005 13 3 182 188 2-s2.0-26944467895
11. Karabinis A., Mandragos K., Stergiopoulos S., Komnos A., Soukup J., Speelberg B., Kirkham A. J., Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Critical Care 2004 8 4 268 280
12. Yang Q.-Y., Xue F.-S., fruitxue@yahoo.com.cn Liao X., Liu H.-P., Luo M.-P., Xu Y.-C., Liu Y., Zhang Y.-M., Comparison of bolus remifentanil versus bolus fentanyl for blunting cardiovascular intubation responses in children: a randomized, double-blind study. Chinese Medical Journal 2009 122 1 44 50 10.3760/cma.j.issn.0366-6999.2009.01.009
13. Breen D., Karabinis A., Malnrain M., Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standart hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised, controlled trial. Critical Care 2005 9 200 210
14. Bonfreschi V., Giuliani E., Malagnino F. C., Navi A., Coppi G., Silingardi R., D'Amico R., Barbieri A., alberto.barbieri@unimore.it Analgesia during abdominal aortic aneurysm endovascular repair: remifentanil vs. fentanyl-midazolam-a randomized controlled trial. European Journal of Anaesthesiology 2009 26 9 782 787 10.1097/EJA.0b013e32832bcc9b
15. Riker R. R., Picard J. T., Fraser G. L., Prospective evaluation of the sedation-agitation scale for adult critically ill patients. Critical Care Medicine 1999 27 7 1325 1329 2-s2.0-0032814036 10.1097/00003246-199907000-00022 (Pubitemid 29379371)
16. Botha J. A., Mudholkar P., The effect of a sedation scale on ventilation hours, sedative, analgesic and inotropic use in an intensive care unit. Critical Care and Resuscitation 2004 6 4 253 257
17. Amor M. B., Ouezini R., Lamine K., Barakette M., Labbène I., Ferjani M., Arrêt journalier delasédation enréanimation chezl'insuffisant rénal: rémifentanil-midazolam versus fentanyl-midazolam. Annales Francaises d'Anesthesie et de Reanimation 2007 26 12 1041 1044 2-s2.0-37049016654 10.1016/j.annfar.2007.10.005 (Pubitemid 350251092)
18. Matthey T., Schill M., Muellejans B., Earlier discharge from ICU with remifentanil / propofol versus fentanyl/midazolam. Journal of Intensive Care Medicine 2004 30 49 51
19. Westmoreland C. L., Hoke J. F., Sebel P. S., Hug C. C., Muir K. T., Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology 1993 79 5 893 903 2-s2.0-0027375940 (Pubitemid 23339046)
20. Navapurkar V. U., Archer S., Gupta S. K., Muir K. T., Frazer N., Park G. R., Metabolism of remifentanil during liver transplantation. British Journal of Anaesthesia 1998 81 6 881 886 2-s2.0-0031744197 (Pubitemid 28561320)
21. Malbrain M., Karabinis A., Morais R., Decreased time on mechanical ventilation using remifentanil-based analgesia and sedation. Critical Care 2004 8 3 238 242
22. Shirasawa Y., Matsumoto M., Yoshimura M., Does high-dose opioid anesthesia exacerbate ischemic spinal cord injury in rabbits? Journal of Anesthesia 2009 23 242 248
23. Bond C. A., Raehl C. L., Pitterle M. E., Franke T., Health care professional staffing, hospital characteristics, and hospital mortality rates. Pharmacotherapy 1999 19 2 130 138 10.1592/phco.19.3.130.30915 (Pubitemid 29072023)
24. Leape L. L., Cullen D. J., Clapp M. D., Burdick E., Demonaco H. J., Erickson J. I., Bates D. W., Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. Journal of the American Medical Association 1999 282 3 267 270 10.1001/jama.282.3.267 (Pubitemid 29343170)
25. Schumock G. T., Meek P. D., Ploetz P. A., Vermeulen L. C., Economic evaluations of clinical pharmacy services. Pharmacotherapy 1996 16 6 I 1188 1208 (Pubitemid 26403663)
26. Hawksworth G. M., Corltt A. J., Wright D. J., Clinical pharmacy intervations by community pharmacists during the dispensing process. British Journal of Clinical Pharmacology 1999 47 695 700 (Pubitemid 29257669)
27. Marshall J., john.marshall@bmc.org Christine A., Theodore A. C., Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Critical Care Medicine 2008 36 2 427 433 10.1097/01.CCM.0000300275.63811.B3 (Pubitemid 351158615)